Clinical Trial Update: The Evaluation of Safety, Tolerability and Pharmacokinetics of Stroke Targeting Drug in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety, tolerability and pharmacokinetics of a stroke-targeting drug in healthy volunteers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Stroke Targeting Drug

Snippet

Sponsor: Jeil Pharmaceutical Co., Ltd. | Conditions: Stroke | Phase 1 | Status: COMPLETED